-- 独立系調査会社CFRAは、に対し、以下の調査レポートを提供しました。CFRAのアナリストは、以下のように見解をまとめています。Uberの第1四半期の売上高は132億ドル(前年同期比14%増)で、市場予想の132億6000万ドルをわずかに下回りました。非GAAPベースの1株当たり利益(EPS)は0.72ドルで、市場予想(0.71ドル)に近い水準となり、前四半期の12%のEPS未達から改善しました。モビリティ事業(7.7%)とデリバリー事業(3.7%)の両方で過去最高の営業利益率を達成したことを考慮すると、これらの市場予想に近い結果は好材料と見ています。悪天候や中東紛争による予約件数の伸びの逆風(60~80ベーシスポイント)にもかかわらず、優れた営業レバレッジが発揮されたことを示しています。総予約件数は25%増(為替変動の影響を除くと21%増)となり、3四半期連続で21%を超える伸びを記録しました。これは、コア事業の勢いが依然として強いことを示しています。第2四半期について、経営陣は為替変動の影響を除いた総予約額が約20%増加し、EPSの中間値は0.80ドル(市場予想は0.81ドル)になると予想しています。プラットフォームの利用状況を示す指標は若干減速しており、MAPCは1億9,900万件(前年同期比+17%、同+22%)、Uber Oneの会員数は5,000万人(前年同期比+50%、同+55%)に達しています。Uberの自動運転車による乗車は現在8都市で利用可能で、2026年末までに15都市での展開が計画されています。第1四半期の自動運転車によるモビリティの乗車数は前年同期比で10倍以上増加しました。
Related Articles
Research Alert: CFRA Lifts View On Shares Of H.f. Sinclair To Buy From Hold
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month target price of $87, raised $31, reflects a combination of relative valuation and DCF models. On a relative basis, we apply a 7.0x multiple of enterprise value to projected 2027 EBITDA. The applied multiple is above DINO's historical forward average, but below peers. We think a modest discount to peers is reasonable on the basis of below-average return on invested capital. Still, a multiple above normal levels for DINO is also reasonable, because we think refining margins will be high in both 2026 and 2027. This approach yields a value of $85 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5%, 2% terminal growth, discounted at a WACC of 7.2%, yields intrinsic value of $89 per share. We lift our 2026 EPS estimate by $2.87 to $7.30 and 2027's by $1.66 to $6.26. In our view, DINO has above-average exposure to middle distillates, which is where we think refining margins will be relatively stronger. Shares yield 2.8%.
CVS Health Raises 2026 Outlook After First-Quarter Beat
CVS Health (CVS) raised its full-year earnings outlook after reporting better-than-expected first-quarter results driven by improvement in its health-care benefits segment.The company raised its 2026 adjusted earnings guidance to $7.30 to $7.50 a share from its previous projection of $7 to $7.20. The consensus on FactSet is $7.16."We are also updating our outlook for full-year cash flow from operations to at least $9.5 billion, reflecting improved underlying performance, primarily related to working capital in our health-care benefits segment," Chief Financial Officer Brian Newman said on the earnings call, according to a FactSet transcript.The stock jumped 7.3% in Wednesday trading and has gained 9.1% this year.CVS maintained its medical benefit ratio guidance, which represents the percentage of premiums spent on medical benefits."This outlook continues to maintain the same respectful and prudent view on medical cost trends until we have greater visibility into how those trends are developing in our pharmacy and consumer wellness segment," Newman said.In the first quarter, adjusted EPS rose to $2.57 from $2.25 a year earlier as revenue climbed 6.2% to $100.43 billion. Wall Street expected EPS of $2.18 on revenue of $94.97 billion.Sales in the health care benefits segment advanced 3.3% to $35.97 billion. "This increase was primarily driven by our government business, partially offset by our exit from the individual exchange business in 2026," Newman said.Revenue in the health-services segment rose 11% to $48.24 billion, while pharmacy and consumer wellness was little changed at $31.99 billion.Price: $86.61, Change: $+5.92, Percent Change: +7.34%
Copper Lake Resources to Launch 20-For-1 Reverse Stock Split
Copper Lake Resources (CPL.V) intends to consolidate its common shares on the basis of 20 pre-consolidation common shares for every one post-consolidation common share effective as of May 8, it said Wednesday.The company currently has 271-million common shares issued and outstanding, and following the consolidation, the company will have about 13.6-million common shares issued and outstanding, prior to rounding for fractional shares.Its outstanding options of 19.5-million and warrants of 15.9-million will also be adjusted on the same basis as the common shares with proportionate adjustments being made to exercise prices.Shares of the company were last seen unchanged at $0.02 on the TSX Venture Exchange.